You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Peptide-Targeted Radioligand Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer Trial in Grand Rapids (SPECT/CT)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • SPECT/CT
  • Grand Rapids, Michigan
    BAMF Health
Apr 19, 2023

Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (225Ac-PSMA-R2, 68Ga-PSMA-R2)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • (no location specified)
Aug 8, 2023

Semi-automated Segmentation Methods of SSTR PET for Dosimetry

Not yet recruiting
  • Refractory Meningioma
  • To evaluate the SUVmean (Standard Uptake Value) as a predictive factor of the tumor absorbed dose compared to the SUVmax
  • (no location specified)
Sep 8, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in San Francisco

Active, not recruiting
  • Castration Levels of Testosterone
  • +6 more
  • Lutetium Lu 177-PSMA-617
  • Pembrolizumab
  • San Francisco, California
    University of California, San Francisco
Apr 11, 2022

Metastatic Merkel Cell Carcinoma Trial in Australia (Avelumab, External Beam Radiation Therapy (EBRT), Lutetium-177

Recruiting
  • Metastatic Merkel Cell Carcinoma
  • Sydney, New South Wales, Australia
  • +5 more
Apr 21, 2021

Mechanisms of Resistance to PSMA Radioligand Therapy

Recruiting
  • Prostate Cancer
  • Single-photon emission computed tomography
  • +2 more
  • Los Angeles, California
  • +2 more
Jun 22, 2022

Solid Tumor Trial in United States (68Ga-FAP-2286, 177Lu-FAP-2286)

Recruiting
  • Solid Tumor
  • Birmingham, Alabama
  • +5 more
Aug 26, 2022

Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Neuroendocrine Neoplasm
  • Arterial Embolization
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Dec 22, 2022

PFS and OS of Advanced Neuroendocrine Cancer After Systemic

Recruiting
  • Neuroendocrine Tumors
    • Olsztyn, Warmińsko-Mazurskie, Poland
    • +1 more
    May 12, 2021

    Metastatic Castration-resistant Prostate Cancer Trial in Oslo (212Pb-NG001)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Oslo, Norway
      Oslo University Hospital
    Feb 13, 2023

    Carcinoid Tumor Lung, Neuroendocrine Tumor of the Lung, Carcinoma, Small-Cell Lung Trial in Iowa City (212-Lead Pentixather,

    Not yet recruiting
    • Carcinoid Tumor Lung
    • +2 more
    • 212-Lead Pentixather
    • 203-Lead Pentixather SPECT/CT
    • Iowa City, Iowa
      The University of Iowa Theranostics Center
    Sep 23, 2022

    Prostate Cancer Trial in London (177Lu-PNT2002, High Dose Radiation)

    Recruiting
    • Prostate Cancer
    • London, Ontario, Canada
      London Health Sciences Centre
    Nov 22, 2022

    Prostate Cancer, Localized Prostate Carcinoma Trial (PSMA-1007 Positron Emission Tomography (PET) scan)

    Not yet recruiting
    • Prostate Cancer
    • Localized Prostate Carcinoma
    • PSMA-1007 Positron Emission Tomography (PET) scan
    • (no location specified)
    Aug 14, 2023

    NSCLC Stage IV, ALK Fusion Protein Expression Trial (Peptide vaccine)

    Not yet recruiting
    • NSCLC Stage IV
    • ALK Fusion Protein Expression
    • Peptide vaccine
    • (no location specified)
    Jul 21, 2023

    Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Atlanta (procedure, radiation, other, drug)

    Not yet recruiting
    • Biochemically Recurrent Prostate Carcinoma
    • Prostate Adenocarcinoma
    • Biospecimen Collection
    • +6 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Oct 25, 2023

    Prostate Cancer Metastatic, Castration Resistant Prostatic Cancer, Advanced Prostate Carcinoma Trial in Homburg

    Recruiting
    • Prostate Cancer Metastatic
    • +2 more
      • Homburg, Saarland, Germany
        Dept. of Nuclear Medicine, Saarland University
      Apr 4, 2021

      Pancreatic Ductal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Glioblastoma Multiforme Trial (68Ga-FF58, 177Lu-FF58)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • +2 more
      • (no location specified)
      Jul 28, 2023

      177Lu-EB-FAPI Trial in Beijing (68Ga-FAPI for PET / CT scan and 177Lu-EB-FAPI for therapy)

      Recruiting
      • 177Lu-EB-FAPI
      • 68Ga-FAPI for PET / CT scan and 177Lu-EB-FAPI for therapy
      • Beijing, Beijing, China
        Peking Union Medical College Hospital, Chinese Academy of Medica
      May 27, 2022

      Pancreatic Neuroendocrine Tumor, Pancreas Cancer Trial in Chicago (cytoreductive surgery, Lutathera - a small molecule used in

      Not yet recruiting
      • Pancreatic Neuroendocrine Tumor
      • Pancreas Cancer
      • cytoreductive surgery
      • +2 more
      • Chicago, Illinois
        The University of Chicago
      Nov 8, 2022

      Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

      Not yet recruiting
      • Neuroendocrine Tumors
      • +8 more
      • Iowa City, Iowa
      • +1 more
      Nov 23, 2022

      Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2

      Recruiting
      • Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care Treatment
      • Duarte, California
      • +12 more
      Jul 6, 2022

      Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)

      Recruiting
      • Salivary Gland Cancer
      • +2 more
      • Nijmegen, Gelderland, Netherlands
        Radboudumc
      Oct 27, 2022

      Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy, Aortic Valve Stenosis Trial in Boston

      Recruiting
      • Heart Failure With Normal Ejection Fraction
      • +3 more
      • Boston, Massachusetts
        Massachusetts General Hospital
      Mar 1, 2022

      Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV Trial in Iowa City, Rochester, Madison ([212Pb]VMT01)

      Not yet recruiting
      • Melanoma (Skin)
      • +5 more
      • Iowa City, Iowa
      • +2 more
      Dec 8, 2022

      Cardiotoxicity, HER2-positive Breast Cancer, Heart Failure Trial in London (Phased withdrawal of heart failure medications)

      Not yet recruiting
      • Cardiotoxicity
      • +3 more
      • Phased withdrawal of heart failure medications
      • London, United Kingdom
      • +1 more
      May 19, 2023